2017-2022 Global and Japan mRNA Vaccines & Therapeutics Market Analysis Report

August 2017 | 116 pages | ID: 26FB2E1AE6EEN
JP Research

Abstracts

The global mRNA Vaccines & Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the mRNA Vaccines & Therapeutics market's development status and future trend in the global and Japan. It splits mRNA Vaccines & Therapeutics market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include

• Argos Therapeutics (U.S.)
• AstraZeneca (UK)
• Bayer AG (Germany)
• BioNTech (Germany)
• Boehringer Ingelheim (Germany)
• CRISPR Therapeutics (Switzerland)
• CureVac (Germany)
• ETheRNA immunotherapies (Belgium)
• Ethris (Germany)
• GlaxoSmithKline Vaccines (UK)
• In-Cell-Art (France)
• Intellia Therapeutics (U.S.)
• Janssen (Belhium)
• Kernal Biologics (U.S.)
• MaxCyte (U.S.)
• Moderna Therapeutics (U.S.)
• Novartis (U.S.)
• PhaseRx (U.S.)
• Precision NanoSystems (Canada)
• RaNa Therapeutics (U.S.)

Geographically, this report splits the Global market into the following regions:

• Asia Pacific
• Japan
• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others
• China
• Korea
• India
• Others
• Europe
• France
• Germany
• United Kingdom
• Italy
• Russia
• Others
• North America
• United States
• Canada
• Latin America
• Brazil
• Mexico
• Others
• Southeast Asia
• Singapore
• Malaysia
• Vietnam
• Myanmar
• Thailand
• Indonesia
• Philippines
• Others
• Middle East & Africa
• Saudi Arabia
• Iran
• UAE
• Turkey
• Israel
• Egypt
• South Africa
• Others

On the basis of product, the mRNA Vaccines & Therapeutics market is primarily split into

By Cancer Vaccines

• Standardized preselected
• Individualized shared antigens
• Individualized neoantigens

By Infectious Disease Vaccines

• Prophylactic vaccines
• Therapeutic vaccines
• Synthetic self-amplifying mRNA vaccines for pandemic outbreaks

By In vivo Therapeutics

• Therapeutic proteins
• Therapeutic antibodies

By Gene Editing

• Ex vivo gene editing of gene defects
• In vivo gene editing of gene defects
• Ex vivo gene editing of autologous and allogeneic T-cells

Key Applications

• Hospital
• Clinic
• Others

Contents

2017-2022 GLOBAL AND JAPAN MRNA VACCINES & THERAPEUTICS MARKET ANALYSIS REPORT

1 MRNA VACCINES & THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Global and Japan mRNA Vaccines & Therapeutics Market by Applications/End Users
  1.2.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Applications (2012-2017)
    1.2.1.2 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global mRNA Vaccines & Therapeutics Sales by Application (2012-2017)
    1.2.3.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Applications (2012-2017)
    1.2.3.2 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
  1.2.5 Hospital
  1.2.6 Clinic
  1.2.7 Others
1.3 Global and Japan Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
    1.3.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
    1.3.2.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017)
    1.3.2.2 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of mRNA Vaccines & Therapeutics by Cancer Vaccines
  1.4.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Cancer Vaccines (2012-2017)
  1.4.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Cancer Vaccines (2012-2017)
  1.4.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Cancer Vaccines (2012-2017)
  1.4.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Cancer Vaccines (2012-2017)
  1.4.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
  1.4.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
  1.4.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Cancer Vaccines (2012-2017)
  1.4.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Cancer Vaccines (2012-2017)
  1.4.9 Standardized preselected
  1.4.10 Individualized shared antigens
  1.4.11 Individualized neoantigens
1.5 Global and Japan Classification of mRNA Vaccines & Therapeutics by Infectious Disease Vaccines
  1.5.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Infectious Disease Vaccines (2012-2017)
  1.5.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Infectious Disease Vaccines (2012-2017)
  1.5.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Infectious Disease Vaccines (2012-2017)
  1.5.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Infectious Disease Vaccines (2012-2017)
  1.5.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
  1.5.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
  1.5.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Infectious Disease Vaccines (2012-2017)
  1.5.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Infectious Disease Vaccines (2012-2017)
  1.5.9 Prophylactic vaccines
  1.5.10 Therapeutic vaccines
  1.5.11 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
1.6 Global and Japan Classification of mRNA Vaccines & Therapeutics by In vivo Therapeutics
  1.6.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by In vivo Therapeutics (2012-2017)
  1.6.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by In vivo Therapeutics (2012-2017)
  1.6.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by In vivo Therapeutics (2012-2017)
  1.6.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by In vivo Therapeutics (2012-2017)
  1.6.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
  1.6.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
  1.6.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by In vivo Therapeutics (2012-2017)
  1.6.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by In vivo Therapeutics (2012-2017)
  1.6.9 Therapeutic proteins
  1.6.10 Therapeutic antibodies
1.7 Global and Japan Classification of mRNA Vaccines & Therapeutics by Gene Editing
  1.7.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Gene Editing (2012-2017)
  1.7.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Gene Editing (2012-2017)
  1.7.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Gene Editing (2012-2017)
  1.7.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Gene Editing (2012-2017)
  1.7.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
  1.7.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
  1.7.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Gene Editing (2012-2017)
  1.7.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Gene Editing (2012-2017)
  1.7.9 Ex vivo gene editing of gene defects
  1.7.10 In vivo gene editing of gene defects
  1.7.11 Ex vivo gene editing of autologous and allogeneic T-cells

2 GLOBAL AND JAPAN MRNA VACCINES & THERAPEUTICS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
  2.1.1 Japan mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan mRNA Vaccines & Therapeutics Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
  2.1.4 Japan mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
    2.1.4.1 Japan mRNA Vaccines & Therapeutics Market Concentration Rate
    2.1.4.2 Japan mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
  2.2.1 Global mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global mRNA Vaccines & Therapeutics Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
  2.2.4 Global mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
    2.2.4.1 Global mRNA Vaccines & Therapeutics Market Concentration Rate
    2.2.4.2 Global mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN MRNA VACCINES & THERAPEUTICS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.1.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.1.1.2 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.1.2 China mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.1.2.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.1.2.2 China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.1.3 Korea mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.1.3.1 Korea mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.1.3.2 Korea mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.1.4 India mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.1.4.1 India mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.1.4.2 India mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.1.5 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.1.5.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.1.5.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
3.2 Europe mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.2.1 France mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.1.1 France mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.1.2 France mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.2.2 Germany mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.2.1 Germany mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.2.2 Germany mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.2.3 United Kingdom mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.3.2 United Kingdom mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.2.4 Italy mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.4.1 Italy mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.4.2 Italy mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.2.5 Russia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.5.1 Russia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.5.2 Russia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.2.6 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.2.6.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.2.6.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
3.3 North America mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.3.1 United States mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.3.1.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.3.1.2 United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.3.2 Canada mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.3.2.1 Canada mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.3.2.2 Canada mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
3.4 Latin America mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.4.1.1 Brazil mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.4.1.2 Brazil mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.4.2 Mexico mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.4.2.1 Mexico mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.4.2.2 Mexico mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.4.3 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.4.3.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.4.3.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
3.5 Southeast Asia mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.1.1 Singapore mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.1.2 Singapore mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.2 Malaysia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.2.2 Malaysia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.3 Vietnam mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.3.2 Vietnam mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.4 Myanmar mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.4.2 Myanmar mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.5 Thailand mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.5.1 Thailand mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.5.2 Thailand mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.6 Indonesia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.6.2 Indonesia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.7 Philippines mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.7.1 Philippines mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.7.2 Philippines mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.5.8 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.5.8.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.5.8.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
3.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.2 Iran mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.2.1 Iran mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.2.2 Iran mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.3 UAE mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.3.1 UAE mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.3.2 UAE mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.4 Turkey mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.4.1 Turkey mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.4.2 Turkey mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.5 Israel mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.5.1 Israel mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.5.2 Israel mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.6 Egypt mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.6.1 Egypt mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.6.2 Egypt mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.7 South Africa mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.7.1 South Africa mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.7.2 South Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
  3.6.8 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
    3.6.8.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
    3.6.8.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)

4 GLOBAL AND JAPAN MRNA VACCINES & THERAPEUTICS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Argos Therapeutics (U.S.)
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 AstraZeneca (UK)
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 Bayer AG (Germany)
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 BioNTech (Germany)
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 BioNTech (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Boehringer Ingelheim (Germany)
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 CRISPR Therapeutics (Switzerland)
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 CureVac (Germany)
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 CureVac (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 ETheRNA immunotherapies (Belgium)
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Ethris (Germany)
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 Ethris (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 GlaxoSmithKline Vaccines (UK)
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 In-Cell-Art (France)
4.12 Intellia Therapeutics (U.S.)
4.13 Janssen (Belhium)
4.14 Kernal Biologics (U.S.)
4.15 MaxCyte (U.S.)
4.16 Moderna Therapeutics (U.S.)
4.17 Novartis (U.S.)
4.18 PhaseRx (U.S.)
4.19 Precision NanoSystems (Canada)
4.20 RaNa Therapeutics (U.S.)

5 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS

5.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN MRNA VACCINES & THERAPEUTICS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
  9.2.1 by Cancer Vaccines
  9.2.2 by Infectious Disease Vaccines
  9.2.3 by In vivo Therapeutics
  9.2.4 by Gene Editing
9.3 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
9.4 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of mRNA Vaccines & Therapeutics
Table Japan mRNA Vaccines & Therapeutics Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of mRNA Vaccines & Therapeutics by Applications in 2016
Table Global mRNA Vaccines & Therapeutics Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of mRNA Vaccines & Therapeutics by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Standardized preselected Product Picture
Figure Individualized shared antigens Product Picture
Figure Individualized neoantigens Product Picture
Figure Prophylactic vaccines Product Picture
Figure Therapeutic vaccines Product Picture
Figure Synthetic self-amplifying mRNA vaccines for pandemic outbreaks Product Picture
Figure Therapeutic proteins Product Picture
Figure Therapeutic antibodies Product Picture
Figure Ex vivo gene editing of gene defects Product Picture
Figure In vivo gene editing of gene defects Product Picture
Figure Ex vivo gene editing of autologous and allogeneic T-cells Product Picture
Table Argos Therapeutics (U.S.) Basic Information List
Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table AstraZeneca (UK) Basic Information List
Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table Bayer AG (Germany) Basic Information List
Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table BioNTech (Germany) Basic Information List
Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table CRISPR Therapeutics (Switzerland) Basic Information List
Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table CureVac (Germany) Basic Information List
Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure CureVac (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table ETheRNA immunotherapies (Belgium) Basic Information List
Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table Ethris (Germany) Basic Information List
Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure Ethris (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table GlaxoSmithKline Vaccines (UK) Basic Information List
Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
Table In-Cell-Art (France) Basic Information List
Table Intellia Therapeutics (U.S.) Basic Information List
Table Janssen (Belhium) Basic Information List
Table Kernal Biologics (U.S.) Basic Information List
Table MaxCyte (U.S.) Basic Information List
Table Moderna Therapeutics (U.S.) Basic Information List
Table Novartis (U.S.) Basic Information List
Table PhaseRx (U.S.) Basic Information List
Table Precision NanoSystems (Canada) Basic Information List
Table RaNa Therapeutics (U.S.) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players/Manufacturers in 2016
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors/Traders List
Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type in 2017
Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type in 2017
Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2017
Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2017
Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
Table Japan mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
Table Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources